Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors
Authors: Benedetta Stefanini et al
Date: 22 Nov 2023
Scope of interest: hepatological
06 99 39
Recup number
You may also be interested in:
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.
Authors: lionetti R
Date: May 2019
Scope of interest: infectious/hepatological
Read details
Outcomes of allogenicstemcelltransplantation for secondary therapy-related acute myeloidleukaemia
Authors:
Date: 2012
Scope of interest: Haematology
Read details
Atrial fibrillation during focal seizures: a case report and literature review.
Authors: Basili LM, Morano A, Fattouch J, Fanella M, Albini M, Ivory F, Irelli EC, Manfredi M, Urani C, Strano S, Giallonardo AT, Di Bonaventura C.
Date: 2019
Scope of interest: Epilepsy
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
